Concepedia

Shabnam Naseer

SN

Statistics

Publications

2

Citations

64

H-Index

2

Active since

2020

Affiliations

Office of Infectious Diseases(Current)

United States Food and Drug Administration

Center for Drug Evaluation and Research

Shabnam Naseer is an author at Office of Infectious Diseases specializing in pharmacy, pharmacology, and nosocomial bloodstream infections.

ORCID

Publications per year

2020–2022

2

Publications

2

US Food and Drug Administration (FDA): Benefit-Risk Considerations for Cefiderocol (Fetroja®)

Shabnam Naseer, Edward A. Weinstein, Daniel B. Rubin et al. · Clinical Infectious Diseases · 2020 · 53 citations

, , +16

Cefiderocol Dosing for Patients Receiving Continuous Renal Replacement Therapy

Xiaohui Wei, Shabnam Naseer, Edward A. Weinstein et al. · Clinical Pharmacology & Therapeutics · 2022 · 11 citations

, , +17

1–2 of 2